no statement of use filed
on 11 Dec 2023
Last Applicant/ Owned by
66 Hudson Boulevard East
New York
NY
100012192
Serial Number
97115555 filed on 09th Nov 2021
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment and prevention of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disordRead More
Pharmaceutical preparations for the treatment and prevention of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Syringes sold filled with anti-arrhythmics, anesthetics, electrolyte solutions, imaging agents or diluents
No 97115555
No Service/Collective Mark
No T435570
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 11th Dec 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 11th Dec 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 07th Apr 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 05th Apr 2023 | SOU TEAS EXTENSION RECEIVED |
| 05th Apr 2023 | SOU EXTENSION 1 FILED |
| 05th Apr 2023 | SOU EXTENSION 1 GRANTED |
| 28th Mar 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 28th Mar 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 28th Mar 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 21st Feb 2023 | ASSIGNED TO EXAMINER |
